Drug Name:
CENTRUM KIDS OTC
Generic Name and Formulations:
Vit. A 1500 IU (53% as beta carotene), thiamine 1.5mg, riboflavin 1.7mg, niacin 20mg, pantothenic acid 10mg, pyridoxine 2mg, Vit. B12 6mcg, biotin 45mcg, folic acid 0.4mg, Vit. C 60mg, Vit. D 400 IU, Vit. E 30 IU, Vit. K 10mcg, calcium (as carbonate) 108mg, iron (as carbonyl) 8mg, chromium 20mcg, copper 2mg, iodine 150mcg, magnesium 40mg, zinc 15mg, manganese 1mg, molybdenum 20mcg, phosphorous 50mg; per chew tab; assorted flavors; contains phenylalanine.
Company:
Pfizer Consumer Healthcare
Therapeutic Use:
Indications for CENTRUM KIDS:
Nutritional supplement.
Adults and Children:
<2yrs: not recommended. Take with food. 2–3yrs: ½ tab once daily ≥4yrs: 1 tab once daily.
Contraindications:
Treatment of pernicious or other megaloblastic anemia. Wilson's disease. Hemochromatosis.
Interactions:
Iron, calcium block tetracycline absorption.
How Supplied:
Tabs—80
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Shifting Dynamics of Social Support After a Cancer Diagnosis
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |